Relay Therapeutics (RLAY) Times Interest Earned (2019 - 2026)
Relay Therapeutics' (RLAY) quarterly Times Interest Earned came in at -$215.32 in Q1 2026, down 131.12% year-on-year from $691.81 in Q1 2025, and up 97.87% on a QoQ basis from -$10105.0 in Q4 2025.
Relay Therapeutics (RLAY) Times Interest Earned (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 8 years of Times Interest Earned data on file, last reported at -$215.32 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 131.12% year-over-year to -$215.32 in Q1 2026; TTM through Mar 2026 was -$812.21, a 101.63% decrease from a year earlier, with the FY2025 full-year figure at -$0.63, up 26.94% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$215.32, up from -$10105.0 in the prior quarter.
- Over the last five years, Times Interest Earned for RLAY reached as high as -$0.2 in Q4 2024 and fell as low as -$10105.0 in Q4 2025.
- Historically, Times Interest Earned has averaged -$690.74 across 5 years, with a median of -$69.72 in 2024.
- Across the five-year window, Times Interest Earned surged 99.94% in 2024 and sank 5136042.51% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$9.61 in 2022, then plunged by 3546.97% to -$350.56 in 2023, then jumped by 99.94% to -$0.2 in 2024, then sank by 5136042.51% to -$10105.0 in 2025, then surged by 97.87% to -$215.32 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$215.32 in Q1 2026, -$10105.0 in Q4 2025, and -$336.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Relay Therapeutics | 3.31 Bn | 3.31 Bn | - | -215.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -215.32 |
| Dec 31, 2025 | -10,105.00 |
| Sep 30, 2025 | -336.36 |
| Jun 30, 2025 | -18.13 |
| Mar 31, 2025 | -93.16 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -323.39 |
| Jun 30, 2024 | -74.63 |
| Mar 31, 2024 | -69.72 |
| Dec 31, 2023 | -350.56 |
| Sep 30, 2023 | -21.73 |
| Jun 30, 2023 | -17.44 |
| Mar 31, 2023 | -15.97 |
| Dec 31, 2022 | -9.61 |
| Sep 30, 2022 | -78.08 |
| Jun 30, 2022 | -6.54 |
| Mar 31, 2022 | -6.80 |
| Dec 31, 2021 | -16.93 |
| Sep 30, 2021 | -60.99 |
| Jun 30, 2021 | -2,419.75 |